109 related articles for article (PubMed ID: 11824552)
1. N-terminal acylation of somatostatin analog with long chain fatty acids enhances its stability and anti-proliferative activity in human breast adenocarcinoma cells.
Dasgupta P; Singh A; Mukherjee R
Biol Pharm Bull; 2002 Jan; 25(1):29-36. PubMed ID: 11824552
[TBL] [Abstract][Full Text] [Related]
2. Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its anti-proliferative activity on human oral carcinoma cells in vitro.
Dasgupta P; Singh AT; Mukherjee R
Life Sci; 2000 Mar; 66(17):1557-70. PubMed ID: 11261586
[TBL] [Abstract][Full Text] [Related]
3. Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its antiproliferative and antiangiogenic activity in vitro.
Dasgupta P; Mukherjee R
Br J Pharmacol; 2000 Jan; 129(1):101-9. PubMed ID: 10694208
[TBL] [Abstract][Full Text] [Related]
4. Lipophilization of somatostatin analog RC-160 improves its bioactivity and stability.
Dasgupta P; Singh AT; Mukherjee R
Pharm Res; 1999 Jul; 16(7):1047-53. PubMed ID: 10450929
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate.
Qin Y; Ertl T; Groot K; Horvath J; Cai RZ; Schally AV
Int J Cancer; 1995 Mar; 60(5):694-700. PubMed ID: 7860145
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the anti-neoplastic effects of tamoxifen by somatostatin analogues.
Pollak M
Digestion; 1996; 57 Suppl 1():29-33. PubMed ID: 8813463
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
Pinski J; Halmos G; Yano T; Szepeshazi K; Qin Y; Ertl T; Schally AV
Int J Cancer; 1994 May; 57(4):574-80. PubMed ID: 7910153
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and GH-inhibitory activity of chimeric peptides consisting of GHRP-6 and somatostatin.
Dasgupta P; Singh AT; Mukherjee R
Biochem Biophys Res Commun; 1999 Jun; 259(2):379-84. PubMed ID: 10362518
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human endometrial cancer cell growth in vitro and in vivo by somatostatin analog RC-160.
Mishima M; Yano T; Jimbo H; Yano N; Morita Y; Yoshikawa H; Schally AV; Taketani Y
Am J Obstet Gynecol; 1999 Sep; 181(3):583-90. PubMed ID: 10486467
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the growth of Caki-I human renal adenocarcinoma in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II.
Jungwirth A; Schally AV; Halmos G; Groot K; Szepeshazi K; Pinski J; Armatis P
Cancer; 1998 Mar; 82(5):909-17. PubMed ID: 9486581
[TBL] [Abstract][Full Text] [Related]
11. Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells.
Sharma K; Srikant CB
Int J Cancer; 1998 Apr; 76(2):259-66. PubMed ID: 9537589
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human epithelial ovarian cancer cell growth in vitro by somatostatin analog RC-160.
Yano T; Radulovic S; Osuga Y; Kugu K; Yoshikawa H; Taketani Y; Schally AV
Oncology; 2000; 59 Suppl 1():45-9. PubMed ID: 11096356
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.
Buscail L; Delesque N; Estève JP; Saint-Laurent N; Prats H; Clerc P; Robberecht P; Bell GI; Liebow C; Schally AV
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2315-9. PubMed ID: 7907795
[TBL] [Abstract][Full Text] [Related]
14. SRA880, in vitro characterization of the first non-peptide somatostatin sst(1) receptor antagonist.
Hoyer D; Nunn C; Hannon J; Schoeffter P; Feuerbach D; Schuepbach E; Langenegger D; Bouhelal R; Hurth K; Neumann P; Troxler T; Pfaeffli P
Neurosci Lett; 2004 May; 361(1-3):132-5. PubMed ID: 15135911
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
Pinski J; Reile H; Halmos G; Groot K; Schally AV
Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
[TBL] [Abstract][Full Text] [Related]
16. Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K
Int J Cancer; 1993 Dec; 55(6):963-7. PubMed ID: 7902829
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice.
Yano T; Pinski J; Szepeshazi K; Halmos G; Radulovic S; Groot K; Schally AV
Cancer; 1994 Feb; 73(4):1229-38. PubMed ID: 8313327
[TBL] [Abstract][Full Text] [Related]
18. Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells.
Srikant CB; Shen SH
Endocrinology; 1996 Aug; 137(8):3461-8. PubMed ID: 8754775
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
20. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
